Seeing Is Believing

Currently out of the existing stock ratings of Steve Byrne, 32 are a SELL (18.6%), 88 are a BUY (51.16%), 52 are a HOLD (30.23%).
Analyst Steve Byrne, currently employed at BAML, carries an average stock price target met ratio of 61.08% that have a potential upside of 24.28% achieved within 245 days.
Steve Byrne’s has documented 658 price targets and ratings displayed on 37 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare sectors.
Most recent stock forecast was given on EMN, Eastman Chemical Company at 02-Feb-2026.
Analyst best performing recommendations are on INVA (INNOVIVA).
The best stock recommendation documented was for INVA (INNOVIVA) at 2/19/2015. The price target of $17 was fulfilled within 1 day with a profit of $0.68 (4.17%) receiving and performance score of 41.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Feb-2025
$180
$11.58 (6.88%)
$100
8 days ago
(18-Feb-2026)
7/10 (70%)
$8.78 (5.13%)
268
Buy Since 10-May-2022
$216
$47.58 (28.25%)
$120
9 days ago
(17-Feb-2026)
27/35 (77.14%)
$49.65 (29.85%)
391
Hold Since 14-Oct-2025
$190
$21.58 (12.81%)
$100
9 days ago
(17-Feb-2026)
11/14 (78.57%)
$23.65 (14.22%)
274
Hold Since 07-Mar-2025
$185
$16.58 (9.84%)
$156
14 days ago
(12-Feb-2026)
31/35 (88.57%)
$26.07 (16.40%)
164
Buy Since 29-Dec-2015
$230
$61.58 (36.56%)
$167
29 days ago
(28-Jan-2026)
12/16 (75%)
$45.67 (24.78%)
485
Which stock is Steve Byrne is most bullish on?
Which stock is Steve Byrne is most reserved on?
What Year was the first public recommendation made by Steve Byrne?